跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ofpred - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ofpred
Approved
STANDARD
Ofpred
Aurolab
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4c1e9a1c0c8e557d
Company
Aurolab
Type
Standard
Approval Details
Approval Id
4c1e9a1c0c8e557d
Drug Approval Philippines Name
Ofpred
Product Name
Ofpred
Registration Number
DRP-5819
Brand Name
Ofpred
Generic Name
Ofloxacin + Prednisolone Sodium Phosphate
Dosage Form
Ophthalmic Solution
Dosage Strength
3mg/5mg (0.3%W/V & 0.5%W/V) Per mL
Manufacturer
Aurolab
Importer
Brady Pharma Inc.
Distributor
Brady Pharma Inc.
Company Detail Path
/organization/aurolab-trust
Issuance Date
08 January 2023
Expiry Date
11 March 2028
Pharmacologic Category
Antibacterial/Corticosteroid
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4c1e9a1c0c8e557d
Type
Standard
Back to Philippines FDA Approvals